S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 26.68 CNY -3.75% Market Closed
Market Cap: 17.7B CNY
Have any thoughts about
Shandong Pharmaceutical Glass Co Ltd?
Write Note

Gross Margin
Shandong Pharmaceutical Glass Co Ltd

29.9%
Current
28%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.9%
=
Gross Profit
1.5B
/
Revenue
5.1B

Gross Margin Across Competitors

Country CN
Market Cap 17.7B CNY
Gross Margin
30%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 37.6B CHF
Gross Margin
55%
Country DK
Market Cap 179.6B DKK
Gross Margin
68%
Country US
Market Cap 15.8B USD
Gross Margin
70%
Country CN
Market Cap 52B CNY
Gross Margin
72%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country KR
Market Cap 9.1T KRW
Gross Margin
15%
Country US
Market Cap 6.2B USD
Gross Margin
65%
Country US
Market Cap 5.7B USD
Gross Margin
47%
Country UK
Market Cap 4.5B GBP
Gross Margin
56%
No Stocks Found

Shandong Pharmaceutical Glass Co Ltd
Glance View

Market Cap
17.7B CNY
Industry
Health Care

In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.

Intrinsic Value
45.92 CNY
Undervaluation 42%
Intrinsic Value
Price
S

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.9%
=
Gross Profit
1.5B
/
Revenue
5.1B
What is the Gross Margin of Shandong Pharmaceutical Glass Co Ltd?

Based on Shandong Pharmaceutical Glass Co Ltd's most recent financial statements, the company has Gross Margin of 29.9%.